XFOR: X4 Pharmaceuticals Inc
今日XFOR汇率已更改1.32%。当日,交易品种以低点3.05和高点3.06进行交易。
关注X4 Pharmaceuticals Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
XFOR新闻
- Down 25.4% in 4 Weeks, Here's Why X4 Pharmaceuticals (XFOR) Looks Ripe for a Turnaround
- X4 Pharmaceuticals (XFOR) Loses 20.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- X4 Pharmaceuticals (XFOR) Upgraded to Buy: Here's Why
- X4 Pharmaceuticals (XFOR) Reports Q2 Loss, Beats Revenue Estimates
- Sarepta Therapeutics (SRPT) Q2 Earnings and Revenues Surpass Estimates
- Bears are Losing Control Over X4 Pharmaceuticals (XFOR), Here's Why It's a 'Buy' Now
- X4 Pharmaceuticals (XFOR) Upgraded to Buy: Here's What You Should Know
- X4 Pharmaceuticals (XFOR) Reports Q1 Loss, Lags Revenue Estimates
- Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates
- Stifel重申X4 Pharmaceuticals股票评级,临床试验进展顺利
- X4 Pharmaceuticals (XFOR) Reports Q4 Loss, Tops Revenue Estimates
- ProQR (PRQR) Reports Q4 Loss, Lags Revenue Estimates
- X4 Pharmaceuticals在Leerink全球医疗保健会议上宣布战略转向罕见血液病领域
- X4 Pharmaceuticals at Leerink Global Healthcare Conference: Strategic Shift to Rare Hematology
- Guggenheim initiates X4 Pharmaceuticals stock with buy rating
- X4 Pharmaceuticals: An Undercovered Biotech Trade With A Funded Path To FDA Approval
- 欧洲药品管理局专家组支持mavorixafor用于超罕见WHIM综合征治疗
- EMA panel backs mavorixafor for ultra-rare WHIM syndrome
- Vericel Corporation (VCEL) Matches Q4 Earnings Estimates
- X4 Pharmaceuticals, Inc. (XFOR) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript
- All You Need to Know About X4 Pharmaceuticals (XFOR) Rating Upgrade to Buy
- Should You Buy X4 Pharmaceuticals (XFOR) After Golden Cross?
- Dynavax Technologies, Omeros, Agios Pharmaceuticals, Nike And Other Big Stocks Moving Higher On Wednesday - Agios Pharmaceuticals (NASDAQ:AGIO), Bioage Labs (NASDAQ:BIOA)
- Stifel将X4制药股票评级上调至"买入",目标价上调至10美元
常见问题解答
XFOR股票今天的价格是多少?
X4 Pharmaceuticals Inc股票今天的定价为3.06。它在3.05 - 3.06范围内交易,昨天的收盘价为3.02,交易量达到5。XFOR的实时价格图表显示了这些更新。
X4 Pharmaceuticals Inc股票是否支付股息?
X4 Pharmaceuticals Inc目前的价值为3.06。股息政策取决于公司,而投资者也会关注3.03%和USD。实时查看图表以跟踪XFOR走势。
如何购买XFOR股票?
您可以以3.06的当前价格购买X4 Pharmaceuticals Inc股票。订单通常设置在3.06或3.36附近,而5和0.33%显示市场活动。立即关注XFOR的实时图表更新。
如何投资XFOR股票?
投资X4 Pharmaceuticals Inc需要考虑年度范围2.43 - 4.83和当前价格3.06。许多人在以3.06或3.36下订单之前,会比较5.88%和。实时查看XFOR价格图表,了解每日变化。
X4 Pharmaceuticals Inc股票的最高价格是多少?
在过去一年中,X4 Pharmaceuticals Inc的最高价格是4.83。在2.43 - 4.83内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪X4 Pharmaceuticals Inc的绩效。
X4 Pharmaceuticals Inc股票的最低价格是多少?
X4 Pharmaceuticals Inc(XFOR)的最低价格为2.43。将其与当前的3.06和2.43 - 4.83进行比较,可以发现潜在的长期切入点。观看XFOR在图表上的实时走势以获取更多详细信息。
XFOR股票是什么时候拆分的?
X4 Pharmaceuticals Inc历史上曾经历过股票拆分。这些变化在公司行动后的、3.02和3.03%中可见。
- 前一天收盘价
- 3.02
- 开盘价
- 3.05
- 卖价
- 3.06
- 买价
- 3.36
- 最低价
- 3.05
- 最高价
- 3.06
- 交易量
- 5
- 日变化
- 1.32%
- 月变化
- 5.88%
- 6个月变化
- -24.44%
- 年变化
- 3.03%
- 实际值
- -3.060 M
- 预测值
- -4.804 M
- 前值
- -8.557 M
- 实际值
- 0.987 M
- 预测值
- -0.153 M
- 前值
- 1.862 M
- 实际值
- 预测值
- 前值
- 5.420%